FPM clinical trial underway at Peter Mac
The CRCBID-sponsored clinical trial into the use of fluoro propyl methionine (FPM) has now studied four patients at Peter Mac.
Approval for the phase 0/1 trial to proceed was given by the Peter Mac Ethics Committee in August 2011, following a first time in human (FTIH) review of the tracer’s manufacturing process.
